Advertisement

Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old?

      Objective

      To determine the number of cleavage-stage embryos that can be safely transferred in women ≥43 years old.

      Design

      Retrospective cohort.

      Setting

      Academic medical center.

      Patient(s)

      All patients ≥43 years old undergoing transfer of five or more cleavage-stage embryos during the period from January 2004 through April 2012.

      Intervention(s)

      In vitro fertilization.

      Main Outcome Measure(s)

      A total of 567 cycles in 464 patients aged 43–45 years, whose IVF cycles were characterized by transfer of five to eight cleavage-stage embryos were identified. Clinical outcomes and risk of multiples were analyzed, stratifying by age and number of embryos transferred.

      Result(s)

      Live birth rates per transfer were 14.4%, 9.4%, and 1.3% for women aged 43, 44, and 45 years, respectively. In 43-year-old women, 2.9% (2/69) of pregnancies were triplet gestations (one selective reduction and one spontaneous reduction). Twin birth rate was 16.3%, 6.7%, and 0 (of all live births) for ages 43, 44, and 45 years, respectively. There was no higher order multiple births. Women aged 43 and 44 years having five or more embryos transferred experienced higher clinical pregnancy rates (PRs) than those patients receiving a transfer of three or four embryos. Clinical outcomes for patients undergoing transfer with six or more embryos were not better than those undergoing transfer with five embryos.

      Conclusion(s)

      Transferring five or more day 3 embryos may be a safe option for patients ≥43 years of age, as it is associated with an overall low rate of multiple gestations. Having more than five embryos available for transfer on day 5 is associated with improved IVF outcomes. Whether this benefit is from the additional embryo(s) for transfer or the inherently better prognosis of such patients remains to be determined.

      Key Words

      To read this article in full you will need to make a payment

      References

        • Practice Committee of American Society for Reproductive Medicine
        • Practice Committee of Society for Assisted Reproductive Technology
        Criteria for number of embryos to transfer: a committee opinion.
        Fertil Steril. 2013; 99: 44-46
        • Reichman D.E.
        • Greenwood E.
        • Meyer L.
        • Kligman I.
        • Rosenwaks Z.
        Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection?.
        Fertil Steril. 2012; 98: 671-674
        • Bromer J.G.
        • Sakkas D.
        • Siano L.J.
        • Benadiva C.A.
        • Patrizio P.
        Reproductive efficiency of women over the age of 40 and the low risk of multiple pregnancies.
        Reprod Biomed Online. 2009; 19: 4316
        • Opsahl M.S.
        • Blauer K.L.
        • Black S.H.
        • Lincoln S.R.
        • Thorsell L.
        • Sherins R.J.
        The number of embryos available for transfer predicts successful pregnancy outcome in women over 39 years with normal ovarian hormonal reserve testing.
        J Assist Reprod Genet. 2001; 18: 551-556
        • Schieve L.A.
        • Peterson H.B.
        • Meikle S.F.
        • Jeng G.
        • Danel I.
        • Burnett N.M.
        • et al.
        Live-birth rates and multiple-birth risk using in vitro fertilization.
        J Am Med Assoc. 1999; 282: 1832-1838
        • Cnattingius S.
        • Forman M.R.
        Delayed childbearing and risk of adverse perinatal outcome. A population-based study.
        J Am Med Assoc. 1992; 268: 886-890
        • Jacobson B.
        • Ladfors L.
        • Milson I.
        Advanced maternal age and adverse perinatal outcome.
        Obstet Gynecol. 2004; 104: 727-733
        • Bianco A.
        • Stone J.
        • Lynch L.
        Pregnancy outcome at age 40 and older.
        Obstet Gynecol. 1996; 87: 917-922
        • Kostas P.M.
        • Vasillis A.
        Influence of advanced age on the blastocyst development rate and pregnancy rate in assisted reproductive technology.
        Fertil Steril. 1999; 71: 1144-1146
        • Scott R.T.
        • Opsahl M.S.
        • Leonardi M.R.
        Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age.
        Hum Reprod. 1995; 10: 1706-1710
        • Rosenwaks Z.
        • Davis O.K.
        • Damario M.A.
        The role of maternal age in assisted reproduction.
        Hum Reprod. 1995; 10: 165-173
        • Tsafrir A.
        • Simon A.
        • Revel A.
        • Reubinoff B.
        • Lewin A.
        • Laufer N.
        Retrospective analysis of 1217 IVF cycles in women aged 40 years and older.
        Reprod Biomed Online. 2007; 14: 348-355
        • Lass A.
        • Croucher C.
        • Duffy S.
        • Dawson K.
        • Margara R.
        • Winston R.M.
        One thousand initiated cycles of in vitro fertilization in women ≥ or = 40 years of age.
        Fertil Steril. 1998; 70: 1030-1034
        • Broekmans F.J.
        • Klinkert E.R.
        Female age in ART: when to stop?.
        Gynecol Obstet Invest. 2004; 58: 225-234
        • Grimbizis G.
        • Vandervorst M.
        • Camus M.
        • Tournaye H.
        • van Steirteghem A.
        • Devroey P.
        Intracytoplasmic sperm injection, results in women older than 39, according to age and the number of embryos replaced in selective or non-selective transfers.
        Hum Reprod. 1998; 13: 884-889
        • Cetinkaya M.B.
        • Siano L.J.
        • Benadiva C.
        • Sakkas D.
        • Patrizio P.
        Reproductive outcome of women 43 years and beyond undergoing ART treatment with their own oocytes in two Connecticut university programs.
        J Assist Reprod Genet. 2013; 30: 673-678
        • Orvieto R.
        • Bar-Hava I.
        • Yoeli R.
        • Ashkenazi J.
        • Rabinerson D.
        • Bar J.
        • et al.
        Results of in vitro fertilization cycles in women aged 43-45 years.
        Gynecol Endocrinol. 2004; 18: 75-78